BSE · SHREEGANES

Shree Ganesh Biotech (India) Limited

Sector: Healthcare · ISIN: INE051N01026

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#4,101

of 5,004 stocks

🏆 New peak

▲ 191W

Peak #4,101 · 01 Oct 2026

A microcap name in Healthcare, Shree Ganesh Biotech (India) Limited carries a steep earnings multiple that prices in strong future growth, is seeing revenue contract sharply, and has a subdued return on equity. Ownership as of Jun 2026.

Market Cap

18.74 Cr

P/E Ratio

47.00

P/B Ratio

0.29

ROE

0.59%

ROCE

0.81%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	1.43 Cr	2.12 Cr	69.81 L	76.74 L
Net Profit	-57.33 L	-14.92 L	32.22 L	1.41 L
EPS	0.01	0.00	0.01	0.00
Operating Profit	-57.33 L	-14.92 L	32.22 L	1.41 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

0.00%

Public

100.00%

PUBLIC BREAKDOWN

FII

1.42%

Individuals

97.05%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
27 Apr 2022	Bonus	Bonus issue 1:1
10 Feb 2022	Split	Stock Split From Rs.10/- to Rs.1/-

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs